Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells
Exposure to maternal cortisol plays a crucial role in fetal organogenesis. However, fetal overexposure to cortisol has been linked to a range of short- and long-term adverse outcomes. Normally, this is prevented by the expression of an enzyme in the placenta called 11-beta hydroxysteroid dehydrogena...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | International Journal of Cell Biology |
Online Access: | http://dx.doi.org/10.1155/2017/6169310 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832566199328702464 |
---|---|
author | Katie L. Togher Louise C. Kenny Gerard W. O’Keeffe |
author_facet | Katie L. Togher Louise C. Kenny Gerard W. O’Keeffe |
author_sort | Katie L. Togher |
collection | DOAJ |
description | Exposure to maternal cortisol plays a crucial role in fetal organogenesis. However, fetal overexposure to cortisol has been linked to a range of short- and long-term adverse outcomes. Normally, this is prevented by the expression of an enzyme in the placenta called 11-beta hydroxysteroid dehydrogenase type 2 (11β-HSD2) which converts active cortisol to its inactive metabolite cortisone. Placental 11β-HSD2 is known to be reduced in a number of adverse pregnancy complications, possibly through an epigenetic mechanism. As a result, a number of pan-HDAC inhibitors have been examined for their ability to promote 11β-HSD2 expression. However, it is not known if the effects of pan-HDAC inhibition are a general phenomenon or if the effects are dependent upon a specific class of HDACs. Here, we examined the ability of pan- and class-specific HDAC inhibitors to regulate 11β-HSD2 expression in JEG3 cells. We find that pan-, class I, or class IIa HDAC inhibition promoted 11β-HSD2 expression and prevented cortisol or interleukin-1β-induced decrease in its expression. These results demonstrate that targeting a specific class of HDACs can promote 11β-HSD2 expression in JEG3 cells. This adds to the growing body of evidence suggesting that HDACs may be crucial in maintaining normal fetal development. |
format | Article |
id | doaj-art-469abb8a4599448b8c8ae4e34233fdc1 |
institution | Kabale University |
issn | 1687-8876 1687-8884 |
language | English |
publishDate | 2017-01-01 |
publisher | Wiley |
record_format | Article |
series | International Journal of Cell Biology |
spelling | doaj-art-469abb8a4599448b8c8ae4e34233fdc12025-02-03T01:04:50ZengWileyInternational Journal of Cell Biology1687-88761687-88842017-01-01201710.1155/2017/61693106169310Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 CellsKatie L. Togher0Louise C. Kenny1Gerard W. O’Keeffe2Department of Obstetrics and Gynaecology, Cork University Maternity Hospital, University College Cork, Cork, IrelandDepartment of Obstetrics and Gynaecology, Cork University Maternity Hospital, University College Cork, Cork, IrelandAPC Microbiome Institute, Biosciences Institute, University College Cork, Cork, IrelandExposure to maternal cortisol plays a crucial role in fetal organogenesis. However, fetal overexposure to cortisol has been linked to a range of short- and long-term adverse outcomes. Normally, this is prevented by the expression of an enzyme in the placenta called 11-beta hydroxysteroid dehydrogenase type 2 (11β-HSD2) which converts active cortisol to its inactive metabolite cortisone. Placental 11β-HSD2 is known to be reduced in a number of adverse pregnancy complications, possibly through an epigenetic mechanism. As a result, a number of pan-HDAC inhibitors have been examined for their ability to promote 11β-HSD2 expression. However, it is not known if the effects of pan-HDAC inhibition are a general phenomenon or if the effects are dependent upon a specific class of HDACs. Here, we examined the ability of pan- and class-specific HDAC inhibitors to regulate 11β-HSD2 expression in JEG3 cells. We find that pan-, class I, or class IIa HDAC inhibition promoted 11β-HSD2 expression and prevented cortisol or interleukin-1β-induced decrease in its expression. These results demonstrate that targeting a specific class of HDACs can promote 11β-HSD2 expression in JEG3 cells. This adds to the growing body of evidence suggesting that HDACs may be crucial in maintaining normal fetal development.http://dx.doi.org/10.1155/2017/6169310 |
spellingShingle | Katie L. Togher Louise C. Kenny Gerard W. O’Keeffe Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells International Journal of Cell Biology |
title | Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells |
title_full | Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells |
title_fullStr | Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells |
title_full_unstemmed | Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells |
title_short | Class-Specific Histone Deacetylase Inhibitors Promote 11-Beta Hydroxysteroid Dehydrogenase Type 2 Expression in JEG-3 Cells |
title_sort | class specific histone deacetylase inhibitors promote 11 beta hydroxysteroid dehydrogenase type 2 expression in jeg 3 cells |
url | http://dx.doi.org/10.1155/2017/6169310 |
work_keys_str_mv | AT katieltogher classspecifichistonedeacetylaseinhibitorspromote11betahydroxysteroiddehydrogenasetype2expressioninjeg3cells AT louiseckenny classspecifichistonedeacetylaseinhibitorspromote11betahydroxysteroiddehydrogenasetype2expressioninjeg3cells AT gerardwokeeffe classspecifichistonedeacetylaseinhibitorspromote11betahydroxysteroiddehydrogenasetype2expressioninjeg3cells |